The Torque Teno Virus Titer in Saliva Reflects the Level of Circulating CD4(+) T Lymphocytes and HIV in Individuals Undergoing Antiretroviral Maintenance Therapy

Carregando...
Imagem de Miniatura
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Citação
FRONTIERS IN MEDICINE, v.8, article ID 809312, 6p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
IntroductionTorque teno virus (TTV) is a non-pathogenic virus present in body fluids. Its titer in the circulation increases in association with immune suppression, such as in HIV-infected individuals. We evaluated if the TTV titer in saliva from HIV-positive individuals undergoing antiretroviral therapy (ART) was related to the circulating CD4+ T lymphocyte concentration and the HIV titer. MethodsSaliva was collected from 276 asymptomatic individuals undergoing ART, and an additional 48 individuals positive for AIDS-associated Kaposi's Sarcoma (AIDS-KS). The salivary TTV titer was measured by gene amplification analysis. The circulating CD4+ T lymphocyte and HIV levels were obtained by chart review. ResultsTTV was detectable in saliva from 80% of the asymptomatic subjects and 87% of those with AIDS-KS. In the asymptomatic group the median log(10) TTV titer/ml was 3.3 in 200 males vs. 2.4 in 76 females (p < 0.0001). TTV titer/ml was 3.7 when HIV was acquired by intravenous drug usage, 3.2 when by sexual acquisition and 2.4 when blood transfusion acquired. The salivary TTV titer was inversely correlated with the circulating CD4+ T lymphocyte level (p < 0.0001) and positively correlated with the circulating HIV concentration (p = 0.0005). The median salivary TTV titer and circulating HIV titer were higher, and the CD4+ count was lower, in individuals positive for AIDS-KS than in the asymptomatic subjects (p < 0.0001). ConclusionThe TTV titer in saliva is a potential biomarker for monitoring immune status in individuals undergoing ART.
Palavras-chave
CD4+lymphocytes, HIV, Kaposi's Sarcoma, saliva, torque teno virus, anellovirus
Referências
  1. Albert E, 2018, J MED VIROL, V90, P1438, DOI 10.1002/jmv.25218
  2. Biagini P, 2009, CURR TOP MICROBIOL, V331, P21
  3. Brassard J, 2015, J CLIN VIROL, V72, P55, DOI 10.1016/j.jcv.2015.08.020
  4. Brundin PMA, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05535
  5. Christensen JK, 2000, J INFECT DIS, V181, P1796, DOI 10.1086/315440
  6. Deng XW, 2000, J MED VIROL, V62, P531, DOI 10.1002/1096-9071(200012)62:4<531::AID-JMV20>3.0.CO;2-C
  7. Elesinnla AR, 2020, ARCH VIROL, V165, P571, DOI 10.1007/s00705-020-04538-1
  8. Haloschan M, 2014, AGE, V36, DOI 10.1007/s11357-014-9716-2
  9. Hettmann A, 2016, INTERVIROLOGY, V59, P123, DOI 10.1159/000452974
  10. Lopes AD, 2020, VIRUS RES, V276, DOI 10.1016/j.virusres.2019.197828
  11. Maggi F, 2003, J VIROL, V77, P9081, DOI 10.1128/JVI.77.16.9081-9083.2003
  12. Maggi F, 2001, J MED VIROL, V64, P190, DOI 10.1002/jmv.1035
  13. Mendes-Correa MC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256357
  14. Nasser TF, 2009, MICROB PATHOGENESIS, V47, P33, DOI 10.1016/j.micpath.2009.04.010
  15. Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765
  16. Okamoto H, 2000, J VIROL, V74, P10236, DOI 10.1128/JVI.74.21.10236-10239.2000
  17. Okamoto H, 1999, VIROLOGY, V259, P428, DOI 10.1006/viro.1999.9770
  18. Puig-Basagoiti F, 2000, J ACQ IMMUN DEF SYND, V23, P89
  19. Ross RS, 1999, J CLIN VIROL, V13, P181, DOI 10.1016/S1386-6532(99)00015-3
  20. Saffier IP, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2795-9
  21. SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980
  22. Schmidt L, 2021, INFECTION, V49, P501, DOI 10.1007/s15010-020-01573-7
  23. Sherman KE, 2001, DIGEST DIS SCI, V46, P2401, DOI 10.1023/A:1012307416122
  24. Shibayama T, 2001, AIDS, V15, P563, DOI 10.1097/00002030-200103300-00004
  25. Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9
  26. Thom K, 2007, J MED VIROL, V79, P1, DOI 10.1002/jmv.20756
  27. Tozetto-Mendoza TR, 2020, REPROD SCI, V27, P2075, DOI 10.1007/s43032-020-00227-1
  28. Tozetto-Mendoza TR, 2018, J INVESTIG CLIN DENT, V9, DOI 10.1111/jicd.12278
  29. Tozetto-Mendoza TR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005291